Jun 2026 (Q2 FY26) — Aug 5, 2026
Orthofix Q2 FY26 — Strong Operational Progress Despite Distributor Headwinds
Read the full callOrthofix (OFIX) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Orthofix earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 211 | +3.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -3.9 | +4.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -15.8 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$9.59 +3.68% · +$0.34
Performance −35.2% 1Y
1Y: $14.79 on 14 Oct 2025 → $9.59. High $16.23 (22 Oct 2025), low $8.64 (17 Sept 2026).
- Previous close
- $9.25
- 52-week range
- $8.64 – $16.23
- One year
- −36.24%
Overview
- Symbol
- OFIX
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Orthofix earnings calls (OFIX)
Financials
What the filings say
Net profit, year on year: −12% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 197 | 216 | 194 | 203 | 206 | 220 | 197 | 211 |
| Operating profit | -19 | -11 | -49 | -16 | -17 | 0 | -14 | -8 |
| Operating margin | −9.6% | −5.3% | −25.2% | −7.9% | −8.3% | 0.2% | −7.3% | −3.9% |
| Profit before tax | -27 | -30 | -52 | -14 | -22 | -2 | -21 | -15 |
| Tax rate | −2.8% | 1.9% | −1.8% | 1.0% | −2.4% | −1.4% | −0.4% | −5.3% |
| Net profit | -27 | -29 | -53 | -14 | -23 | -2 | -21 | -16 |
| EPS ($ per share) | -0.71 | — | -1.35 | -0.36 | -0.57 | — | -0.52 | -0.39 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 4 |
| Reserves | 87 | 58 | 59 | 21 | 1 | -150 | -276 | -368 |
| Total liabilities | 131 | 168 | 169 | 140 | 122 | 327 | 390 | 401 |
| Fixed assets | 43 | 63 | 64 | 59 | 58 | 159 | 140 | 129 |
| Total assets | 467 | 496 | 526 | 477 | 459 | 925 | 893 | 851 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 50 | 32 | 74 | 18 | -12 | -46 | 26 | 33 |
| Cash from investing | -61 | -23 | -52 | -23 | -25 | -33 | -28 | -35 |
| Cash from financing | 3 | -11 | 3 | -4 | -0 | 65 | 51 | -1 |
| Net cash flow | -9 | -2 | 26 | -9 | -37 | -13 | 48 | -1 |
| Capital expenditure | -14 | -19 | -15 | -18 | -21 | -60 | -35 | -35 |
| Free cash flow | 36 | 13 | 59 | 1 | -33 | -106 | -9 | -1 |
Insider filings
59 filings between Jan 9, 2026 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
$6.82M
18 purchases by 4 insiders
Sales
$3.87M
26 sales by 8 insiders
8% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 15
- Award — granted as compensation
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Juniper Investment Company, LLC | $2.73M | $2.99M | Sep 21, 2026 |
| Engine Capital Management, LP | $3.97M | — | May 7, 2026 |
| Calafiore Massimo | — | $456.6K | Mar 5, 2026 |
| Andrews Julie | — | $131.1K | Mar 5, 2026 |
| Cedron Jorge Andres | — | $83.3K | Apr 16, 2026 |
| Vitale Lucas | — | $80.3K | Mar 17, 2026 |
| McPherron Aviva | — | $67.0K | Jun 18, 2026 |
| CAPPS VICKIE L | $62.3K | — | Mar 10, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Fisher Patrick President, Global Limb Recon | Sale 10b5-1 plan | 150 | $1.4K |
| Sep 21, 2026 | Juniper Investment Company, LLC 10% owner | Purchase | 190,000 | $1.68M |
| Sep 18, 2026 | Juniper Investment Company, LLC 10% owner | Purchase | 120,000 | $1.05M |
| Sep 1, 2026 | Fisher Patrick President, Global Limb Recon | Sale 10b5-1 plan | 150 | $1.4K |
| Aug 18, 2026 | Fisher Patrick President, Global Limb Recon | Sale | 1,295 | $13.1K |
| Aug 17, 2026 | Juniper Investment Company, LLC 10% owner | Sale | 20,000 | $200.3K |
| Aug 14, 2026 | Juniper Investment Company, LLC 10% owner | Sale | 19,500 | $202.5K |
| Jun 18, 2026 | McPherron Aviva Pres, Global Ops & Qual | Sale | 3,670 | $34.4K |
| Jun 10, 2026 | BURRIS WAYNE Director | Award | 14,965 | $0 |
| Jun 10, 2026 | Bazaar Alan Lee Director | Award | 14,965 | $0 |
| Jun 10, 2026 | Paolucci Michael E Director | Award | 14,965 | $0 |
| Jun 10, 2026 | Hannon Jason Director | Award | 14,965 | $0 |
| Jun 10, 2026 | Finegan Michael Director | Award | 20,721 | $0 |
| Jun 10, 2026 | Maniar Shweta Director | Award | 14,965 | $0 |
| Jun 10, 2026 | Kummeth Charles R. Director | Award | 14,965 | $0 |
| Jun 10, 2026 | CAPPS VICKIE L Director | Award | 14,965 | $0 |
| Jun 10, 2026 | HENNEMAN JOHN B III Director | Award | 14,965 | $0 |
| May 22, 2026 | Juniper Investment Company, LLC 10% owner | Sale | 242,000 | $2.59M |
| May 7, 2026 | HENNEMAN JOHN B III Director | Purchase | 5,000 | $61.3K |
| May 7, 2026 | Engine Capital Management, LP 10% owner | Purchase | 9,096 | $110.5K |
| May 7, 2026 | Engine Capital Management, LP 10% owner | Purchase | 1,808 | $22.1K |
| May 7, 2026 | Engine Capital Management, LP 10% owner | Purchase | 18,192 | $221.9K |
| May 7, 2026 | Engine Capital Management, LP 10% owner | Purchase | 904 | $11.0K |
| May 6, 2026 | Engine Capital Management, LP 10% owner | Purchase | 3,792 | $46.4K |
| May 6, 2026 | Engine Capital Management, LP 10% owner | Purchase | 38,154 | $466.5K |
| May 5, 2026 | Engine Capital Management, LP 10% owner | Purchase | 110,039 | $1.32M |
| May 5, 2026 | Engine Capital Management, LP 10% owner | Purchase | 2,911 | $34.9K |
| Apr 16, 2026 | Cedron Jorge Andres CLO | Sale | 3,743 | $48.0K |
| Mar 17, 2026 | Vitale Lucas CP&BOO | Sale | 4,269 | $50.9K |
| Mar 10, 2026 | CAPPS VICKIE L Director | Purchase | 100 | $1.2K |
| Mar 10, 2026 | CAPPS VICKIE L Director | Purchase | 2,400 | $29.9K |
| Mar 9, 2026 | CAPPS VICKIE L Director | Purchase | 2,500 | $31.2K |
| Mar 5, 2026 | Cedron Jorge Andres CLO | Sale | 1,370 | $17.2K |
| Mar 5, 2026 | Andrews Julie CFO | Sale | 2,363 | $29.7K |
| Mar 5, 2026 | Vitale Lucas CP&BOO | Sale | 1,141 | $14.3K |
| Mar 5, 2026 | Calafiore Massimo President & CEO | Sale | 6,031 | $75.7K |
| Mar 5, 2026 | Fisher Patrick President, Global Limb Recon | Sale | 758 | $9.5K |
| Mar 5, 2026 | McPherron Aviva Pres, Global Ops & Qual | Sale | 1,263 | $15.9K |
| Mar 5, 2026 | REINHARDT MAX President, Global Spine | Sale | 1,053 | $13.2K |
| Mar 4, 2026 | REINHARDT MAX President, Global Spine | Sale | 1,080 | $13.9K |
| Mar 4, 2026 | Cedron Jorge Andres CLO | Sale | 1,405 | $18.1K |
| Mar 4, 2026 | McPherron Aviva Pres, Global Ops & Qual | Sale | 1,296 | $16.7K |
| Mar 4, 2026 | Andrews Julie CFO | Sale | 2,425 | $31.3K |
| Mar 4, 2026 | Vitale Lucas CP&BOO | Sale | 1,171 | $15.1K |
| Mar 4, 2026 | Calafiore Massimo President & CEO | Sale | 6,189 | $79.9K |
| Mar 4, 2026 | Fisher Patrick President, Global Limb Recon | Sale | 778 | $10.0K |
| Mar 3, 2026 | Calafiore Massimo President & CEO | Award | 115,119 | $0 |
| Mar 3, 2026 | Fisher Patrick President, Global Limb Recon | Award | 21,105 | $0 |
| Mar 3, 2026 | McPherron Aviva Pres, Global Ops & Qual | Award | 23,024 | $0 |
| Mar 3, 2026 | Andrews Julie CFO | Award | 35,495 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Orthofix Medical Inc.
Free account. Everything above stays public.
Write why you follow Orthofix Medical Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading